Table 2B.
Prevalence of abnormal Ca, P, 25(OH)vitD, and BTMs levels (n = 95).
| Index | High | Normal | Low |
|---|---|---|---|
| pre-Ca, %(N) | 22.10 (21) | 69.50 (66) | 8.40 (8) |
| post-Ca, %(N) | 12.60 (12) | 82.10 (78) | 5.30 (5) |
| pre-P, %(N) | 4.30 (4) | 21.30 (20) | 74.50 (71) |
| post-P, %(N) | 22.10 (21) | 76.80 (73) | 1.10 (1) |
| pre-25(OH)vitD, %(N) | 69.50 (66) | 29.40 (28) | 1.10 (1) |
| post-25(OH)vitD, %(N) | 69.50 (66) | 30.50 (29) | 0.00 (0) |
| pre-OC, %(N) | 5.50 (5) | 8.80 (8) | 85.70 (82) |
| post-OC, %(N) | 10.60 (10) | 74.70 (71) | 14.70 (14) |
| pre-BALP, %(N) | / | 74.70 (71) | 25.30 (24) |
| post-BALP, %(N) | / | 69.50 (66) | 30.50 (29) |
| pre-NTx, %(N) | 6.30 (6) | 3.20 (3) | 90.50 (86) |
| post-NTx, %(N) | 6.30 (6) | 19.10 (18) | 73.7 (70) |
| pre-CTx, %(N) | / | 1.10 (1) | 98.90 (94) |
| post-CTx, %(N) | / | 22.10 (21) | 77.9 (74) |
Abbreviations: Ca, calcium; P, phosphorus; 25(OH)vitD, 25-hydroxyvitamin D; BTMs, bone turnover markers; OC, osteocalcin; BALP, bone specific alkaline phosphatase; NTx, Type I collagen cross-linked N-terminal peptide; CTx, Type I collagen cross-linked C-terminal peptide.